(Q38050307)

27 August 2017

title

Tumor necrosis factor-alpha and the cytokine network in psoriasis (English)

1 reference

27 August 2017

Arles Martins Brotas

1

1 reference

27 August 2017

José Marcos Tellas Cunha

2

1 reference

27 August 2017

Eduardo Henrique Jorge Lago

3

1 reference

27 August 2017

Cristiane Chaves Nascentes Machado

4

1 reference

27 August 2017

Sueli Coelho da Silva Carneiro

5

1 reference

27 August 2017

publication date

1 September 2012

1 reference

Anais Brasileiros de Dermatologia

27 August 2017

published in

1 reference

27 August 2017

volume

87

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

673-81; quiz 682-3

1 reference

The expanding universe of T-cell subsets: Th1, Th2 and more.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Connections between psoriasis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

IL-22 increases the innate immunity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

The isomorphic response of Koebner

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

IL-1 pathways in inflammation and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

An immune origin of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

A guide to immunotherapy of genital warts: focus on interferon and imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

T(H)-17 cells in the circle of immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Distinct regulation of interleukin-17 in human T helper lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

The pathophysiology of tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

The tumor necrosis factor ligand and receptor families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Biology of tumor necrosis factor-alpha- implications for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Shock and tissue injury induced by recombinant human cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Psoriasis. Immunopathology and immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500001

10.1590/S0365-05962012000500001

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference